Last update 01 Nov 2024

Bristol-Myers Squibb Australia Pty Ltd.

Subsidiary Company|
1930|
Australia
|
www.bmsa.com.au

Overview

Tags

Digestive System Disorders
Infectious Diseases
Skin and Musculoskeletal Diseases
Small molecule drug
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases4
Immune System Diseases3
Neoplasms3
Nervous System Diseases2
Endocrinology and Metabolic Disease2
Hemic and Lymphatic Diseases2
Top 5 Drug TypeCount
Monoclonal antibody3
Small molecule drug3
Top 5 TargetCount
PD-1(Programmed cell death protein 1)1
CTLA4(Cytotoxic T-Lymphocyte-Associated Antigen 4)1
TYK2(Tyrosine-protein kinase 2)1
LAG3 x PD-11
RT(Viral reverse transcriptase)1

Related

6
Drugs associated with Bristol-Myers Squibb Australia Pty Ltd.
Deucravacitinib
Target
TYK2
Mechanism
TYK2 inhibitors
Active Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co. [+5]
Originator Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Active Indication
Erythrodermic psoriasis [+15]
Inactive Indication
Alopecia Areata [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date09 Sep 2022
Mavacamten
Target
Cardiac myosin
Mechanism
Cardiac myosin inhibitors
Active Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co. [+6]
Originator Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Active Indication
Hypertrophic obstructive cardiomyopathy [+3]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date28 Apr 2022
Nivolumab/Relatlimab
Target
LAG3 x PD-1
Mechanism
LAG3 inhibitors [+1]
Active Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co. [+5]
Originator Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Active Indication
Metastatic melanoma [+7]
Inactive Indication
HER2 negative Gastroesophageal Junction Adenocarcinoma [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date18 Mar 2022
6
Clinical Trials associated with Bristol-Myers Squibb Australia Pty Ltd.
ACTRN12611000303943 / CompletedPhase 1
A Phase 1 Study to determine the effect of a high fat meal on the pharmacokinetics of Brivanib in Healthy Subjects.
ACTRN12610001043022 / Not yet recruitingPhase 1
A Phase 1, Partially Blinded, Placebo-Controlled, study of Intravenously Administered BMS-943539 to assess the pharmacokinetics and in particular the mean T-HALF of BMS-943539 across all doses in healthy male subjects.
ACTRN12609000026224 / RecruitingPhase 3
A Phase 3, Active (Warfarin) Controlled, Randomized,Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban inPreventing Stroke and Systemic Embolism in Subjects with Nonvalvular AtrialFibrillation
100 Clinical Results associated with Bristol-Myers Squibb Australia Pty Ltd.
Login to view more data
0 Patents (Medical) associated with Bristol-Myers Squibb Australia Pty Ltd.
Login to view more data
100 Deals associated with Bristol-Myers Squibb Australia Pty Ltd.
Login to view more data
100 Translational Medicine associated with Bristol-Myers Squibb Australia Pty Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
6
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free